{"id":"https://openalex.org/W2017604806","doi":"https://doi.org/10.1111/j.1476-5381.1983.tb09403.x","title":"Calcium antagonist and the peripheral circulation: differences and similarities between PY 108\u2013068, nicardipine, verapamil and diltiazem","display_name":"Calcium antagonist and the peripheral circulation: differences and similarities between PY 108\u2013068, nicardipine, verapamil and diltiazem","publication_year":1983,"publication_date":"1983-02-01","ids":{"openalex":"https://openalex.org/W2017604806","doi":"https://doi.org/10.1111/j.1476-5381.1983.tb09403.x","mag":"2017604806","pmid":"https://pubmed.ncbi.nlm.nih.gov/6831117","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2044696"},"language":"en","primary_location":{"id":"doi:10.1111/j.1476-5381.1983.tb09403.x","doi":"https://doi.org/10.1111/j.1476-5381.1983.tb09403.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1983.tb09403.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1983.tb09403.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1983.tb09403.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111615591","display_name":"Robert P. Hof","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4388891806","display_name":"Sandoz Group AG (Switzerland)","ror":"https://ror.org/02rse7p59","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4388891806"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Robert P. Hof","raw_affiliation_strings":["Cardiovascular Unit of Preclinical Research, Sandoz Ltd, CH-4002 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular Unit of Preclinical Research, Sandoz Ltd, CH-4002 Basel, Switzerland","institution_ids":["https://openalex.org/I4388891806"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5111615591"],"corresponding_institution_ids":["https://openalex.org/I4388891806"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":15.1292,"has_fulltext":true,"cited_by_count":131,"citation_normalized_percentile":{"value":0.9936696,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"78","issue":"2","first_page":"375","last_page":"394"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.7153000235557556,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.7153000235557556,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":0.12330000102519989,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11700","display_name":"Hemodynamic Monitoring and Therapy","score":0.0215000007301569,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/calcium-channel-blockers","display_name":"calcium channel blockers","score":0.8840000033378601},{"id":"https://openalex.org/keywords/dihydropyridines","display_name":"dihydropyridines","score":0.9760000109672546},{"id":"https://openalex.org/keywords/nicardipine","display_name":"nicardipine","score":0.9819999933242798},{"id":"https://openalex.org/keywords/verapamil","display_name":"verapamil","score":0.9990000128746033},{"id":"https://openalex.org/keywords/diltiazem","display_name":"diltiazem","score":1.0},{"id":"https://openalex.org/keywords/regional-blood-flow","display_name":"regional blood flow","score":0.8259999752044678},{"id":"https://openalex.org/keywords/peripheral-circulation","display_name":"peripheral circulation","score":0.7419999837875366},{"id":"https://openalex.org/keywords/coronary-blood-flow","display_name":"coronary blood flow","score":0.8370000123977661},{"id":"https://openalex.org/keywords/cerebral-blood-flow","display_name":"cerebral blood flow","score":0.9860000014305115},{"id":"https://openalex.org/keywords/skeletal-muscle-blood-flow","display_name":"skeletal muscle blood flow","score":0.9819999933242798},{"id":"https://openalex.org/keywords/vasodilation","display_name":"vasodilation","score":0.8389999866485596},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.5680000185966492},{"id":"https://openalex.org/keywords/cardiac-output","display_name":"cardiac output","score":0.6330000162124634},{"id":"https://openalex.org/keywords/nifedipine","display_name":"nifedipine","score":0.781000018119812},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.375}],"concepts":[{"id":"https://openalex.org/C2778043224","wikidata":"https://www.wikidata.org/wiki/Q729213","display_name":"Nicardipine","level":3,"score":0.9563267827033997},{"id":"https://openalex.org/C2776741139","wikidata":"https://www.wikidata.org/wiki/Q422229","display_name":"Diltiazem","level":3,"score":0.9551149606704712},{"id":"https://openalex.org/C2777022698","wikidata":"https://www.wikidata.org/wiki/Q410291","display_name":"Verapamil","level":3,"score":0.8788955211639404},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.6593310236930847},{"id":"https://openalex.org/C46762472","wikidata":"https://www.wikidata.org/wiki/Q178648","display_name":"Peripheral","level":2,"score":0.5129844546318054},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.5001533031463623},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46508923172950745},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34342730045318604},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.3366185128688812},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.33190807700157166},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002415","descriptor_name":"Cats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004110","descriptor_name":"Diltiazem","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006439","descriptor_name":"Hemodynamics","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008863","descriptor_name":"Microspheres","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009431","descriptor_name":"Neural Conduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009529","descriptor_name":"Nicardipine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009543","descriptor_name":"Nifedipine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D009543","descriptor_name":"Nifedipine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012039","descriptor_name":"Regional Blood Flow","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D014700","descriptor_name":"Verapamil","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1476-5381.1983.tb09403.x","doi":"https://doi.org/10.1111/j.1476-5381.1983.tb09403.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1983.tb09403.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1983.tb09403.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2044696","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2044696","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"},{"id":"pmid:6831117","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6831117","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/j.1476-5381.1983.tb09403.x","doi":"https://doi.org/10.1111/j.1476-5381.1983.tb09403.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1983.tb09403.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1983.tb09403.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2017604806.pdf","grobid_xml":"https://content.openalex.org/works/W2017604806.grobid-xml"},"referenced_works_count":41,"referenced_works":["https://openalex.org/W83991394","https://openalex.org/W1561174251","https://openalex.org/W1986613486","https://openalex.org/W1991772915","https://openalex.org/W2007182079","https://openalex.org/W2008717306","https://openalex.org/W2021553590","https://openalex.org/W2028907713","https://openalex.org/W2031343827","https://openalex.org/W2036417518","https://openalex.org/W2041184529","https://openalex.org/W2043623939","https://openalex.org/W2049907486","https://openalex.org/W2054445365","https://openalex.org/W2072877321","https://openalex.org/W2084680926","https://openalex.org/W2089258817","https://openalex.org/W2089945924","https://openalex.org/W2102896366","https://openalex.org/W2122689055","https://openalex.org/W2132924014","https://openalex.org/W2142653656","https://openalex.org/W2154216905","https://openalex.org/W2154512973","https://openalex.org/W2200883212","https://openalex.org/W2409229957","https://openalex.org/W2410507808","https://openalex.org/W2411860504","https://openalex.org/W2413710421","https://openalex.org/W2413983911","https://openalex.org/W2417190567","https://openalex.org/W2417551936","https://openalex.org/W2418379826","https://openalex.org/W2418628105","https://openalex.org/W2419491576","https://openalex.org/W2425510151","https://openalex.org/W2432526609","https://openalex.org/W2461720530","https://openalex.org/W2466096268","https://openalex.org/W2467854765","https://openalex.org/W4241262452"],"related_works":["https://openalex.org/W2008717306","https://openalex.org/W2440939403","https://openalex.org/W2335992599","https://openalex.org/W2036157860","https://openalex.org/W2038359669","https://openalex.org/W2031594749","https://openalex.org/W2402822643","https://openalex.org/W1984211609","https://openalex.org/W2059979142","https://openalex.org/W2469585194"],"abstract_inverted_index":{"1":[0],"The":[1,47,147,216,297,336],"effects":[2,148,317],"of":[3,58,67,79,134,149,256,292,295,318,338],"two":[4,13,162],"dihydropyridines,":[5],"PY":[6],"108-068":[7],"(PY)":[8],"and":[9,12,19,72,84,91,104,119,129,166,175,205,306,310,324,326],"nicardipine":[10],"(N),":[11],"other":[14,197,330],"calcium":[15],"antagonists,":[16],"verapamil":[17,150],"(V)":[18],"diltiazem":[20],"(D),":[21],"on":[22,321,328,332],"regional":[23],"blood":[24,89,142,229,245,308],"flow":[25,128,143,156,172,230,246,309],"were":[26,51,151,260,279,302],"measured":[27],"in":[28,132,188,224,241,252,304],"open-chest":[29],"cats,":[30],"anaesthetized":[31],"with":[32,195,258],"chloralose-urethane.2":[33],"Each":[34],"substance":[35],"was":[36,98,108,157,178,235,272],"infused":[37],"at":[38],"3":[39],"different":[40],"dose":[41],"rates,":[42],"each":[43],"for":[44,61,70,82,267],"10":[45,54,63],"min.":[46],"total":[48,93],"doses":[49],"given":[50],"5":[52],"plus":[53,55,64,74,76],"35":[56],"(total":[57,66,78],"50)":[59],"mug/kg":[60,69,81],"PY,":[62],"70":[65],"100)":[68],"N":[71],"100":[73],"200":[75],"700":[77],"1000)":[80],"V":[83,120,167,325],"D.3":[85],"All":[86,124,138],"substances":[87,125,139],"lowered":[88,99],"pressure":[90],"increased":[92,110,126,141,158,186],"peripheral":[94,283,354],"conductance.":[95],"Heart":[96],"rate":[97],"only":[100,111,179],"by":[101,112,160],"V,":[102],"D":[103,116,165,327],"PY.":[105],"Cardiac":[106],"output":[107],"markedly":[109],"the":[113,135,145,161,184,201,203,206,221,311,315,319,329],"diyhydroypridine":[114],"derivatives;":[115],"had":[117,168],"small":[118,176],"almost":[121],"no":[122],"effects.4":[123],"coronary":[127,305],"redistributed":[130],"it":[131],"favour":[133],"subepicardial":[136],"layer.":[137],"also":[140],"to":[144,173,183,200,214,248,263,344,349],"brain.":[146],"comparatively":[152],"small.5":[153],"Skeletal":[154],"muscle":[155,334],"strongly":[159],"dihydropyridine":[163],"derivatives.":[164],"negligible":[169],"effects.6":[170],"Blood":[171],"stomach":[174],"intestine":[177],"slightly":[180,187],"increased.":[181],"Flow":[182,199],"kidneys":[185],"diltiazem-treated":[189],"animals":[190],"but":[191],"did":[192,286],"not":[193],"change":[194],"all":[196],"treatments.":[198],"liver,":[202],"adrenals,":[204],"spleen":[207],"remained":[208],"unchanged":[209],"or":[210],"showed":[211,232],"a":[212,236,289],"tendency":[213,237],"decrease.7":[215],"organ":[217],"conductances":[218],"which":[219],"reflect":[220],"active":[222],"changes":[223],"vascular":[225,340],"tone":[226],"better":[227],"than":[228],"values,":[231],"that":[233,270],"there":[234],"towards":[238],"vasodilatation":[239],"even":[240],"most":[242,298,312],"organs":[243],"where":[244],"tended":[247],"decrease.8":[249],"Results":[250],"obtained":[251],"an":[253],"earlier":[254],"series":[255],"experiments":[257],"nifedipine":[259,271],"very":[261],"similar":[262],"those":[264],"described":[265],"here":[266],"N,":[268],"except":[269],"about":[273],"twice":[274],"as":[275,353],"potent.9":[276],"Calcium":[277],"antagonists":[278],"thus":[280],"neither":[281],"general":[282],"vasodilators":[284],"nor":[285],"they":[287],"show":[288],"uniform":[290],"pattern":[291],"preferential":[293],"sites":[294],"action.":[296],"important":[299,313],"common":[300],"features":[301],"increases":[303],"cerebral":[307],"differences":[314],"divergent":[316],"dihydropyridines":[320,347],"one":[322],"side":[323,331],"skeletal":[333],"flow.":[335],"size":[337],"this":[339],"bed":[341],"may":[342],"help":[343],"explain":[345],"why":[346],"appear":[348],"be":[350],"particularly":[351],"potent":[352],"vasodilators.":[355]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}